|
|
|
|
Direct Cost |
Indirect Cost |
|
261201100016C-6-0-1 |
Preclinical Pharmacokinetic and Pharmacological Studies of Antitumor and other Th |
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO |
NCI |
|
|
$93,783 |
267200700005C-11-0-1 |
United States Renal Data System ¿ Nutrition/malnutrition Special Study Center |
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO |
NIDDK |
|
|
$402,534 |
268200900014C-10-0-4 |
SPIROMICS |
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO |
NHLBI |
|
|
$167,688 |
268201100005I-0-26800002-1 |
Recipient Epidemiology and Donor Evaluation Study III (REDS-III) Domestic Hub |
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO |
NHLBI |
|
|
$3,684,071 |
268201100009I-0-26800002-1 |
Recipient Epidemiology and Donor Evaluation Study III (REDS-III) Internat'l Site |
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO |
NHLBI |
|
|
$5,732,604 |
268201300057C-0-0-1 |
IGF::OT::IGF Sjogren's International Collaborative Clinical Alliance (SICCA) Bior |
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO |
NHLBI |
|
|
$2,096,364 |
271201300042C-0-0-1 |
Analytical Services Center for Medications Development Program |
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO |
NIDA |
|
|
$100,000 |
275201300006I-0-27500001-1 |
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE |
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO |
NICHD |
|
|
$54,908 |
275201300006I-0-27500002-2 |
CCTN - CONTRACEPTIVE EFFICACY AND SAFETY OF DAILY ORAL ULIPRISTAL ACETATE |
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO |
NICHD |
|
|
$878,528 |
N01AI70002-12-0-1 |
Tissue Based Small Animal Model for HIV Drug Discovery |
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO |
NIAID |
|
|
$1,759,386 |
N01HR56166-16-0-1 |
Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome |
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO |
NHLBI |
|
|
$99,759 |
N01HR56166-16-0-4 |
ARDS - SAILS Protocol |
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO |
NHLBI |
|
|
$414,528 |
1DP2HD080351-01 |
Total synthesis of the human mammary gland |
UNIVERSITY OF CALIFORNIA SAN FRANCISCO |
NICHD |
$1,500,000 |
$872,625 |
$2,372,625 |
1DP2HL123228-01 |
Resolving Incomplete Penetrance in the Cardiomyopathies and Channelopathies |
UNIVERSITY OF CALIFORNIA SAN FRANCISCO |
NHLBI |
$1,500,000 |
$855,000 |
$2,355,000 |
1DP5OD017887-01 |
A novel RNA-guided platform for sequence-specific cell reprogramming |
UNIVERSITY OF CALIFORNIA SAN FRANCISCO |
OD |
$250,000 |
$142,917 |
$392,917 |
1DP5OD017895-01 |
Formation and regulation of the translating mRNP |
UNIVERSITY OF CALIFORNIA SAN FRANCISCO |
OD |
$250,000 |
$108,045 |
$358,045 |
1DP7OD018420-01 |
Motivating INformed Decisions (MIND): Careers for the Future Biomedical Workforce |
UNIVERSITY OF CALIFORNIA SAN FRANCISCO |
OD |
$227,630 |
$100,157 |
$327,787 |
1F30CA174154-01 |
Targeting the translational apparatus in MYCN-driven pediatric solid tumors |
UNIVERSITY OF CALIFORNIA SAN FRANCISCO |
NCI |
$35,307 |
|
$35,307 |
1F30DE023280-01A1 |
The Role of Iron in Ameloblast Differentiation and Enamel Fluorosis |
UNIVERSITY OF CALIFORNIA SAN FRANCISCO |
NIDCR |
$39,466 |
|
$39,466 |
1F30DE023476-01 |
Mapping Orofacial Nociceptive Pathways and Alterations Due to Inflammation |
UNIVERSITY OF CALIFORNIA SAN FRANCISCO |
NIDCR |
$39,466 |
|
$39,466 |